Latest News & Updates
Breaking News
1 day ago
Vaibhavi M.
Other trending news you may like to read
Axplora Consolidates Global UDCA API Manufacturing at India's Vizag Facility After European Exit
Axplora exits Italian UDCA production, consolidating global API supply at its GMP-certified Vizag facility with capacity and sustainability gains.
Vaibhavi M.
FDA and NIH Launch Three-Part ClinicalTrials.gov Compliance Training for Sponsor-Investigators in July 2026
FDA and NIH host a three-part virtual training on ClinicalTrials.gov compliance, covering reporting deadlines, PRS functionality, and enforcement risk for sponsor-investigators.
Vaibhavi M.
Optimi Health Completes First GMP Psilocybin Export to UK for Phase 2 Clinical Trial
Optimi Health ships GMP psilocybin capsules to the UK under dual Health Canada and Home Office authorization, establishing a procedural template for psychedelic clinical supply.
Vaibhavi M.
FDA Issues Six Drug Safety Communications Requiring Labeling Updates Across OTC, Opioid, and GLP-1 Product Lines
Six FDA Drug Safety Communications issued in 2026 impose labeling obligations across OTC, opioid, and GLP-1 product lines, tightening post-market compliance timelines.
Vaibhavi M.
